KM Financial Solutions | UPDATE 1-Cost to insure Bristol-Myers debt jumps as leverage balloons
42087
post-template-default,single,single-post,postid-42087,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 1-Cost to insure Bristol-Myers debt jumps as leverage balloons

UPDATE 1-Cost to insure Bristol-Myers debt jumps as leverage balloons

The cost to insure Bristol-Myers
Squibb debt hit its highest point since May 2010 on
Thursday, following the announcement that the U.S.
pharmaceutical company would acquire rival Celgene Corp
in a deal worth about $74 billion.

No Comments

Sorry, the comment form is closed at this time.